Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time ...

FDA Device Recall #Z-1748-2025 — Class II — April 28, 2025

Recall Summary

Recall Number Z-1748-2025
Classification Class II — Moderate risk
Date Initiated April 28, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Molecular, Inc.
Location Des Plaines, IL
Product Type Devices
Quantity 1447 units

Product Description

Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the qualitative detection and differentiation of RNA from influenza A virus (flu A), influenza B virus (flu B), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 in nasopharyngeal (NP) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection

Reason for Recall

There were reports of an increase in reactive negative controls and false positive results.

Distribution Pattern

Worldwide - US Nationwide distribution.

Lot / Code Information

UDI-DI: 00884999049338; Lot Numbers: 409383 410627 411921

Other Recalls from Abbott Molecular, Inc.

Recall # Classification Product Date
Z-1749-2025 Class II Alinity m Resp-4-Plex AMP Kit, List Number 09N7... Apr 28, 2025
Z-1665-2025 Class II The Alinity m System is designed to automate th... Mar 20, 2025
Z-0233-2025 Class II Abbott Alinity m HPV AMP Kit, used with the Ali... Sep 12, 2024
Z-0234-2025 Class II Abbott Alinity m STI AMP Kit, used with the Ali... Sep 12, 2024
Z-1602-2024 Class II Alinity m System, Part Number: 08N53-002 Mar 20, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.